Cited by 93Neuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanismsNeuroscience and Neuropharmacology Research

Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity

Open access
Zhao, Xiao-Feng, Alam, Mahabub Maraj, Liao, Yuan, Huang, Tingting, Mathur, Ramkumar, Zhu, Xinjun, Huang, Yunfei·2019·eneuro

Abstract

Microglia play a pivotal role in maintaining homeostasis of the CNS. There is growing interest in understanding how microglia influence normal brain function and disease progression. Several microglia-specific Cx3cr1-Cre lines have been developed and have become indispensable tools in many investigations of microglial function. However, some recent studies have reported that these lines may have significant leakage into neurons. Other studies have reported that Cx3cr1 is expressed in non-microglial cells, including neurons and astrocytes, in vitro or in vivo either during brain development or upon neurological insult. All these reports raise serious concerns about the trustworthiness of these Cre-lines and whether the conclusions drawn from previous studies are valid. Here, we found that a floxed fluorescent reporter mouse line which has been frequently used to verify Cre lines displayed spontaneous expression of the GFP reporter, independent of Cre recombinase, thus revealing a potential caveat in assessing cre lines. We further confirmed that two Cx3cr1-Cre mouse lines can drive fluorescent reporter expression largely restrictively in microglia. Finally, we clarified that these two mouse lines maintain microglia-specific expression even following excitatory injury. Together, our findings confirm that two previously created Cx3cr1-Cre lines remain as invaluable tools for studying microglia. Moreover, to ensure the quality of data generated and the soundness of conclusions drawn from such data, it should be compulsory to thoroughly examine reporter lines for spontaneous leakiness when labeling cells to study CNS function and diseases.

AI snapshot

Written from the paper’s full text.

TL;DR

This study re-evaluates Cx3cr1-Cre microglia specificity and finds that two commonly used floxed fluorescent reporter lines, Rosa-Green and tdTomato, can leak independent of Cre, whereas mT/mG does not. It confirms that Cx3cr1-CreM and Cx3cr1-CreERT2J lines largely restrict reporter expression to microglia, including after pilocarpine-induced status epilepticus, though the inducible line has tamoxifen-independent basal activity.

Key findings

  • Rosa-Greenf/f mice showed spontaneous, Cre-independent GFP leakiness: 33.33% of animals had significant GFP expression throughout the brain; among GFP+ cells, cortex Iba1+/NeuN+/GFAP+ populations were 2.80 ± 2.45%, 17.42 ± 15.66%, and 0%, and hippocampus populations were 0%, 41.71 ± 15.45%, and 0.47 ± 0.83%, respectively. Triple-negative GFP+ cells were 79.8% in cortex and 57.8% in hippocampus.
  • tdTomatof/f mice showed Cre-independent tdTomato leakage in all seven animals examined, predominantly vascular and colocalized with lectin; cortex Iba1+/NeuN+/GFAP+ populations were 2.00 ± 4.5%, 4.00 ± 8.9%, and 0%, and hippocampus values were 0, 44 ± 0.9%, 0.70 ± 1.6%, and 0.88 ± 1.2% as reported. In contrast, mT/mGf/f mice showed no mGFP leakage in all seven mice examined.
  • Cx3cr1-CreM±;Rosa-Greenf/- mice had 99.2 ± 0.3% and 99.8 ± 0.16% of microglia GFP-positive in cortex and hippocampus; NeuN+/GFP+ were 0.13 ± 0.5% and 0%, and GFAP+/GFP+ were 0% and 0.2 ± 0.5%. With mT/mG, 99.9 ± 0.17% and 99.7 ± 0.36% of GFP+ cells were Iba1+ in cortex and hippocampus, with none NeuN+ or GFAP+.
  • Cx3cr1-CreERT2J±;mT/mGf/- mice showed basal Cre activity without tamoxifen: up to 18.9 ± 4.3% and 23.0 ± 3.4% of Iba1+ cells were GFP+ in cortex and hippocampus; after tamoxifen, all Iba1+ cells were GFP+, with none NeuN+ or GFAP+. After pilocarpine-induced status epilepticus, Cx3cr1-CreM±;Rosa-Greenf/- showed 98.8 ± 1.1% and 99.6 ± 0.24% of GFP+ cells as Iba1+ in cortex and hippocampus, and Cx3cr1-Cre±;mT/mGf/- showed 99.9 ± 0.13% and 100% GFP+ microglia.

Methods

  • Male and female mice were used, including Rosa-Greenf/f, tdTomatof/f, mT/mGf/f, Cx3cr1-CreERT2, and Cx3cr1-CreM lines; brains were harvested at around two to six months for reporter evaluation, around two months for Cx3cr1-CreM crosses, and after tamoxifen or pilocarpine treatment as specified.
  • Immunohistochemistry used antibodies against GFP, Iba1, NeuN, and GFAP, with lectin for blood vessels; 35-µm coronal sections near bregma –2 mm were imaged by confocal microscopy, and GFP+/Iba1+, GFP+/NeuN+, and GFP+/GFAP+ cells were quantified in cortex, CA1, CA3, and dentate gyrus.
  • Tamoxifen was given at 100 mg/kg i.p. for five consecutive days; pilocarpine was given with methyl scopolamine to induce status epilepticus for 4 h, with brains harvested 3 d post-status epilepticus; data were analyzed with GraphPad Prism 7 and presented as mean ± SEM.

Limitations

  • The paper does not include a formal limitations section; it states that the exact mechanism of spontaneous leakiness in Rosa-Greenf/f and tdTomatof/f remains unclear, that no reliable anti-Cx3cr1 antibody is available, and that discrepancies with prior studies require further study.
  • Evident from the text: sample sizes are small, often two to three mice per group, with seven mice for reporter-line evaluations, and sex distributions are not balanced across all experiments.
  • Evident from the text: quantification is restricted to selected cortical and hippocampal regions, and the authors note that prior reported ~10% neuronal leakage in the Cx3cr1-CreM line was not accompanied by data, leaving external validation incomplete.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1523/eneuro.0114-19.2019

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

33 of 36 cited sources checked · 10 supported · 8 flagged · accuracy not yet measured

  • Premisecitation

    No leakiness was reported in those studies using the YFP reporter line to verify two inducible Cx3cr1-CreERT2 lines.

    “No leakiness was reported in those studies.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Jung et al., 2000 source

      The Results and Discussion describes a CX3CR1–EGFP knock-in mouse, not YFP reporter validation of two inducible Cx3cr1-CreERT2 lines. Searches for YFP, inducible Cre and leakiness found no passage addressing whether those lines showed uninduced reporter activity. Page numbers were not available in our copy. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites Parkhurst et al., 2013 source

      The Results section, “Generation of CX3CR1CreER mice to manipulate gene expression in microglia” (page not available), reports DsRed-positive microglia even without tamoxifen, contrary to the claim that no leakiness was reported. EYFP marked cells expressing the CreER transcript; the paper used a DsRed reporter to test Cre-mediated recombination. (LLM, conf=0.89)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Findingown data

    The inducible Cx3cr1-CreERT2 line developed by Jung et al. (2000) displayed some basal cre activity without tamoxifen treatment.

    “The inducible Cx3cr1-CreERT2 line developed by Jung et al. (2000), displayed some basal cre activity without tamoxifen treatment, but this expression was restricted to microglia.”
    • Also stated in: § Discussion · plain
      “We found that this inducible line can drive expression of GFP reporter in a fraction of microglia before tamoxifen treatment.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Jung et al. (2000) source

      The Results and Discussion describe a CX3CR1–GFP knock-in mouse, not an inducible Cx3cr1-CreERT2 line. Materials and Methods say Cre was introduced transiently into embryonic stem cells to remove a selection gene; the paper does not report basal Cre activity or tamoxifen treatment. (LLM, conf=0.90)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Findingown data

    This basal cre activity in the Cx3cr1-CreERT2 line developed by Jung et al. (2000) was restricted to microglia.

    “The inducible Cx3cr1-CreERT2 line developed by Jung et al. (2000), displayed some basal cre activity without tamoxifen treatment, but this expression was restricted to microglia.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Jung et al. (2000) source

      The Results and Discussion describe a CX3CR1-GFP reporter mouse, not an inducible Cx3cr1-CreERT2 line. Materials and Methods say Cre was used transiently in embryonic stem cells to remove a selection cassette; the paper does not report basal Cre activity or tamoxifen treatment. Its GFP expression was also observed in peripheral blood monocytes, not only microglia. (LLM, conf=0.90)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Premisecitation

    According to The Jackson Laboratory website, the constitutive Cx3cr1-Cre line created by Jung et al. (2000) displays leakiness into neurons when crossed with a yellow fluorescent protein (YFP) reporter line.

    “According to the description on The Jackson Laboratory website, the constitutive Cx3cr1-Cre line created by Jung et al. (2000), displays leakiness into neurons when crossed with a yellow fluorescent protein (YFP) reporter line.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Jung et al. (2000) source

      The Results and Discussion section (‘Generation of CX3CR-1GFP mice’; page not provided) says Jung et al. generated a CX3CR1–EGFP replacement line, not a constitutive Cx3cr1-Cre line. The Methods say Cre was used transiently in embryonic stem cells to remove the neo gene. The paper does not report a YFP-reporter cross or neuronal leakiness. (LLM, conf=0.88)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Interpretationreasoning

    The partial tamoxifen-independent cre activity observed in the Cx3cr1-CreERT2 line developed by Jung et al. (2000) indicates potential embryonic deletion of TSC1 in a fraction of microglia.

    “The partial tamoxifen-independent cre activity observed in the Cx3cr1-CreERT2 line developed by Jung et al. (2000), indicates potential embryonic deletion of TSC1 in a fraction”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Jung et al. (2000) source

      The Results and Discussion section identifies the line Jung et al. generated as CX3CR1-GFP mice, not Cx3cr1-CreERT2 mice. Materials and Methods says Cre was used transiently in embryonic stem cells to remove a selectable marker; it does not report tamoxifen-independent Cre activity or TSC1 deletion in microglia. (LLM, conf=0.88)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. 11
  • May combine two claims. 13
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim.

    Premisecitation

    Cx3cr1-CreERT2 developed by Jung et al. (2000) was reported to drive microglia-specific expression.

    “Cx3cr1-CreERT2 developed by Jung et al. (2000) was reported to drive microglia-specific expression.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Jung et al. (2000) source

      The Results and Discussion describe a CX3CR1-GFP reporter mouse, not a Cx3cr1-CreERT2 mouse. Although GFP was observed in microglia, the same section reports expression in peripheral blood monocytes and subsets of NK and dendritic cells, contrary to microglia-specific expression. (LLM, conf=0.90)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Wang et al. reported that transient expression of Cx3cr1 in neurons is neuronal protective in an ischemic model.

    “Wang et al., reported that transient expression of Cx3cr1 in neurons is neuronal protective in an ischemic model (Wang et al., 2018).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Wang et al., 2018 source

      The Discussion states the opposite: elevated neuronal CX3CR1 is associated with apoptotic death, while CX3CR1 deficiency protects against ischemic brain damage. The study used a permanent, not transient, ischemia model. The supplied passages have section labels but no page numbers. (LLM, conf=0.94)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    The leakiness of this Cx3cr1-Cre line was recently reported, but in conjunction with a Rosa-Greenf/f reporter line (Zhang et al., 2018).

    “The leakiness of this Cx3cr1-Cre line was recently reported, but in conjunction with a Rosa-Greenf/f reporter line (Zhang et al., 2018).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Zhang et al., 2018 source
  • May combine two claims.

    Interpretationreasoning

    If the YFP reporter line has no spontaneous leakiness, then the constitutive Cx3cr1-Cre line developed by Jung et al. (2000), now available at The Jackson Laboratory, is not microglia specific.

    “If the YFP reporter line has no spontaneous leakiness, then the constitutive Cx3cr1-Cre line developed by Jung et al. (2000), and which is now available at The Jackson Laboratory, is not microglia specific.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Jung et al. (2000) source

      The Results and Discussion report CX3CR1 expression in microglia and in non-microglial cells, including peripheral blood monocytes and dendritic cells, supporting the concern about microglia specificity. But the Generation of CX3CR-1GFP mice section describes an EGFP knock-in, not a constitutive Cx3cr1-Cre line. Our copy does not establish that Jung et al. developed the Cre line, that it is available at The Jackson Laboratory, or how it behaves with a YFP reporter. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In Hwang et al. (2017), the GFP reporter line was created by the researchers themselves.

    “Moreover, in the same study, the GFP reporter line was created by the researchers themselves.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Hwang et al., 2017 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The Cx3cr1-CreM line was deployed in Hwang et al. (2017), who found it to drive microglial-specific expression of a reporter.

    “Notably, this Cre-line was also deployed in a recent study by Hwang et al. (2017), who found it to drive microglial-specific expression of a reporter.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Hwang et al. (2017) source

      The Results section (page unavailable) reports that Cx3cr1-Cre; Pabpc1cTag mice showed highly restricted PABP-GFP expression matching cell-type markers, supporting the reporter-expression finding. But the paper calls the line Cx3cr1-Cre, not Cx3cr1-CreM, and STAR Methods (page unavailable) notes occasional GFP expression in neurons; our copy therefore does not establish the exact line designation or absolute microglial specificity. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Hwang et al. (2017) briefly mentioned that ∼10% of their animals displayed significant leakage into neurons, but the data were not provided.

    “However, the authors also briefly mentioned that ∼ 10% of their animals displayed significant leakage into neurons, but the data were not provided (Hwang et al., 2017).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Hwang et al., 2017 source

      STAR METHODS (Experimental Model and Subject Details; page unavailable) reports occasional GFP-expression leakiness in neuronal lineages in fewer than 10% of tested Cx3cr1-Cre; Pabpc1cTag mice. This supports the central observation, but the paper does not call the leakage significant or give a figure documenting those cases; its stated rate is <10%, rather than approximately 10%. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    The expression pattern of Cx3cr1-driven GFP reporter is specific to microglia over the entire period of postnatal brain development and appears to be maintained even following an excitatory injury.

    “The expression pattern of Cx3cr1-driven GFP reporter is specific to microglia over the entire period of postnatal brain development and appears to be maintained even following an excitatory injury (Kim et al., 2015).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Kim et al., 2015 source

      In Results (‘Cx3Cr1GFP/+ are identified as microglia’; page unavailable), GFP substantially overlaps the microglial marker IBA1 in P15 mice both before and after febrile seizures, and microglia greatly outnumber infiltrating macrophages and monocytes after induced seizures. But the paper says Cx3Cr1 can also be expressed by other antigen-presenting cells, so the reporter is not established as specific to microglia. Although the developmental study spans P0–P60, reporter specificity was checked at P15, not throughout that period. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    Tamoxifen treatment led to broad expression of GFP reporter in microglia, without significant leakage into neurons, in the Cx3cr1-CreERT2 line developed by Jung et al. (2000).

    “Nevertheless, tamoxifen treatment led to broad expression of GFP reporter in microglia, without significant leakage into neurons.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Jung et al. (2000) source

      The Results and Discussion (page not available in our copy) report GFP expression in microglia of CX3CR1+/GFP mice. The Methods and Results describe a GFP knock-in, not a Cx3cr1-CreERT2 line, and do not report tamoxifen treatment or assess GFP leakage into neurons; the stated absence of GFP concerns astrocytes and oligodendrocytes. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Meucci et al. (2000) reported that Cx3cr1 is expressed in cultured neurons and promotes neuronal survival.

    “Meucci et al. (2000) reported that Cx3cr1is expressed in cultured neurons and promotes neuronal survival.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Meucci et al. (2000) source
  • May combine two claims.

    Premisecitation

    In Wang et al., the IHC data showed that the majority of Cx3cr1-positive cells were neurons and very few, if any, were microglia.

    “However, oddly, the IHC data showed that the majority of Cx3cr1-positive cells were neurons and very few, if any, were microglia.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Wang et al., 2018 source

      In Results, Figure 2, the double staining is described as showing CX3CR1 mainly in ischemic neurons, supporting the majority-neuronal part of the claim. The same Results section reports CX3CR1 upregulation in microglia at a relatively lower level at 24 hours, but does not establish that very few, if any, CX3CR1-positive cells were microglia. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    Among GFP-positive cells in the cortex of Rosa-Greenf/f mice, Iba1+, NeuN+, and GFAP+ populations are 2.80 ± 2.45%, 17.42 ± 15.66%, and 0%, respectively.

    “Among the GFP-positive cells in the cortex, Iba1+, NeuN+, and GFAP+ populations are 2.80 ± 2.45%, 17.42 ± 15.66%, and 0%, respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The leakiness of GFP reporter in Rosa-Greenf/f mice varied significantly between the two hemispheres and among animals even in the same age group.

    “The leakiness varied significantly between the two hemispheres (Extended Data Fig. 1-1A) and among animals even in the same age group.”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    The entire mouse body can turn pinkish in color in tdTomato mice with broad spontaneous leakage.

    “The entire mouse body can turn pinkish in color.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In Cx3cr1-CreM±;Rosa-Greenf/- mice, NeuN+/GFP+ and GFAP+/GFP+ populations are 0.13 + 0.5% and 0% in cortex, and 0% and 0.2 ± 0.5% in hippocampus, respectively.

    “NeuN+/GFP+ and GFAP+/GFP+ populations are 0.13 + 0.5% and 0%, in the cortex, and 0% and 0.2 ± 0.5% in the hippocampus, respectively.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Endogenous Cx3cr1 is a selective marker for microglia in the CNS.
  • May combine two claims.

    Findingown data

    mTomato is expressed in various brain structures but is noticeably present in the hippocampal CA3 area and in the blood vessels.

    “Indeed, mTomato is expressed in various brain structures but is noticeably present in the hippocampal CA3 area and in the blood vessels (Extended Data Fig. 1-2C,D).”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of Cre recombinase, whereas expression of membrane tagged-GFP (mGFP) requires Cre-mediated homologous recombination.
  • May combine two claims.

    Findingown data

    In the hippocampus of tdTomato reporter mice, Iba1+, NeuN+, and GFAP+ populations are 0, 44 ± 0.9%, 0.70 ± 1.6%, and 0.88 ± 1.2%, respectively.

    “In the hippocampus, Iba1+, NeuN+, and GFAP+ populations are 0, 44 ± 0.9%, 0.70 ± 1.6%, and 0.88 ± 1.2%, respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Among tdTomato-positive cells in the cortex, Iba1+, NeuN+, and GFAP+ populations are 2.00 ± 4.5%, 4.00 ± 8.9%, and 0%, respectively.

    “Among the tdTomato positive cells in the cortex, Iba1+, NeuN+, and GFAP+ populations are 2.00 ± 4.5%, 4.00 ± 8.9%, and 0%, respectively.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationreasoning

    In the absence of a reliable anti-Cx3cr1 antibody, it is hard to draw any conclusions from these studies.

    “In the absence of a reliable anti-Cx3cr1 antibody, it is hard to draw any conclusions from these studies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In Yeo et al., nearly 100% of the Cx3cr1-positive cells were astrocytes.

    “Nearly 100% of the Cx3cr1-positive cells were astrocytes.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Yeo et al. (2011) source
  • Classified as probably not a substantial claim.

    Premisecitation

    Yeo et al. (2011) reported that pilocarpine-triggered SE induced very moderate expression of Cx3cr1 in astrocytes.

    “Yeo et al. (2011) reported that pilocarpine-triggered SE induced very moderate expression of Cx3cr1 in astrocytes, but again the IHC data are puzzling.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Yeo et al. (2011) source
21 of 21
  • The paper relies on this without support.

    Endogenous Cx3cr1 is a selective marker for microglia in the CNS.

    “Endogenous Cx3cr1 is a selective marker for microglia in the CNS, whereas its ligand fractalkine is expressed in neurons.”
  • The authors state this as an assumption.

    Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of Cre recombinase, whereas expression of membrane tagged-GFP (mGFP) requires Cre-mediated homologous recombination.

    “Mice are expected to express membrane tagged-Tomato (mTomato) ubiquitously independent of cre recombinase whereas the expression of membrane tagged-GFP(mGFP) requires cre-mediated homologous recombination.”
  • The paper relies on this without support.

    The reliability of Cre-dependent GFP reporter lines has not been seriously evaluated or even discussed.

    “While Cre lines have been blamed for the cause of leakiness into neurons, the reliability of Cre-dependent GFP reporter lines has not been seriously evaluated or even discussed.”
3 of 3

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • The same stock number identifies two different mouse lines

    Minor

    Stock #005582 is identified first as a Cx3cr1-GFP reporter line and later as a Cx3cr1-CreERT2 inducible Cre line. These are described as different genetic tools.

1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, X.-F., Alam, M. M., Liao, Y., Huang, T., Mathur, R., Zhu, X., & Huang, Y.
Affiliations
Albany Medical College (US)
Venue
eneuro
Published
2019-06-14
Volume
6
Issue
4
Pages
ENEURO.0114-19.2019
ISSN
2373-2822 (ISSN-L)
OpenAlex
W2952334185
Cited by
92
References
22
Citations by year
2026: 13 · 2025: 12 · 2024: 19 · 2023: 13 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 2 · 2018: 1
FWCI
3.14
Type
journal article
Language
en
Open access
Locations
  • eNeuro (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
Funders
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NS093045)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK099566)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
microglia, astrocytes, neurons, CNS homeostasis
MeSH terms
CX3C Chemokine Receptor 1, Animals, Astrocytes, Brain, Female, Male, Mice, Transgenic, Neurons, Reproducibility of Results, Gene Expression, Microglia, Genes, Reporter, Integrases, Green Fluorescent Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-20.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-20.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review